Related Experiment Videos
Pneumococcal vaccine strategy. Feasibility of a vaccination program directed at hospitalized and ambulatory patients
Insights
Pneumococcal vaccination for hospitalized patients is feasible. Targeting high-risk individuals, including those recently hospitalized, can effectively prevent serious pneumococcal infections.
Area of Science:
- Infectious Diseases
- Public Health
- Vaccinology
Background:
- Pneumococcal infections pose a significant public health burden.
- Previous vaccination rates among hospitalized patients are low.
- Identifying high-risk populations is crucial for effective prevention strategies.
Purpose of the Study:
- To assess the feasibility of an inpatient pneumococcal vaccination program.
- To evaluate the potential effectiveness of targeting hospitalized patients.
- To explore vaccination strategies for preventing serious pneumococcal infections.
Main Methods:
- Prospective analysis of patients hospitalized with pneumococcal infection.
- Data collection over an 18-month period at two hospitals.
- Assessment of previous vaccination status and recent hospitalization history.
Main Results:
- Only 8% of 113 hospitalized patients had received the pneumococcal vaccine.
- 67% of patients had been hospitalized at least once in the prior three years.
- 100% of patients with regular medical care had outpatient visits in the prior three years.
Conclusions:
- A vaccination program targeting hospitalized, high-risk patients is potentially effective.
- Vaccinating high-risk ambulatory patients is a viable strategy for prevention.
- Inpatient vaccination offers a key opportunity to increase pneumococcal immunization rates.
Abstract:
A prospective analysis of patients hospitalized with pneumococcal infection at two Rochester (NY) hospitals was performed during an 18-month period to assess the feasibility of a pneumococcal vaccination program directed at inpatients. Of the 113 patients hospitalized with pneumococcal infection, only nine patients (8%) had previously received pneumococcal vaccine and 76 patients (67%) had been hospitalized at least once in the previous three years. Of the 104 patients who had a source of regular medical care, 100% had made at least one outpatient visit in the previous three years. The association between the acquisition of a serious pneumococcal infection and hospitalization within the previous three years suggests that a vaccination strategy directed at hospitalized high-risk patients would be potentially effective. Also, vaccination of high-risk ambulatory patients remains a viable strategy to prevent serious pneumococcal infection.